Table 7.

Bioavailability and drug-likeness predictions of substances 4–17 in addition to Acarbose and Gliclazide.

Cpd. No.	Lipinski (violations)	Veber (violations)	Ghose (violations)	Egan (violations)	Muegge (violations)	Bioavailability Score	PAINS alerts	Synthetic Accessibility
4	0	0	0	0	0	0.55	0	3.44
5	0	0	0	0	0	0.55	0	3.54
6	0	0	0	0	0	0.55	0	3.7
7	0	0	0	0	0	0.55	0	3.43
8	0	0	0	0	0	0.55	0	3.56
9	0	0	0	0	1	0.55	0	3.75
10	0	0	0	0	0	0.55	1	3.66
12	1	0	3	1	3	0.55	1	4.78
13	1	0	3	1	3	0.55	1	4.78
14	0	0	0	0	0	0.55	0	3.03
15	0	0	0	0	0	0.55	0	3.99
16	0	0	0	0	0	0.55	0	4.09
17	0	0	0	0	0	0.55	0	4.09
Acarbose	3	1	4	1	5	0.17	0	7.34
Gliclazide	0	0	0	0	0	0.55	0	3.52